id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
APHIS-2011-0048-0050,APHIS,APHIS-2011-0048,"Viruses, Serums, Toxins, and Analogous Products: Exemptions from Preparation Pursuant to Unsuspended and Unrevoked License",Proposed Rule,Notice of Proposed Rulemaking (NPRM),2012-09-20T04:00:00Z,2012,9,2012-09-20T04:00:00Z,2012-11-17T04:59:59Z,2012-11-14T03:06:44Z,2012-23202,0,0,090000648111ff93
APHIS-2011-0048-0001,APHIS,APHIS-2011-0048,"Viruses, Serums, Toxins, and Analogous Products: Exemptions from Preparation Pursuant to an Unsuspended and Unrevoked License",Proposed Rule,Notice of Proposed Rulemaking (NPRM),2012-07-18T04:00:00Z,2012,7,2012-07-18T04:00:00Z,2012-11-17T04:59:59Z,2012-11-07T03:00:41Z,2012-17533,0,0,090000648109faf1